Similar articles

• Comparison of the excretion of different types of melanogens in the melanoma patients.

  Matous B, Pavel S, Budĕsínská A, Duchon J, Mechl Z, Sopková B. Matous B, et al. Neoplasma. 1979;26(5):597-602. Neoplasma. 1979. PMID: 118388
• Chromatography of melanogens from urine of hamsters with transplantable melanoms. I. Thormählen-positive melanogens.

  Pavel S, Schwippelová Z, Duchon J, Matous B, Vulterin K. Pavel S, et al. J Chromatogr. 1978 Jul 11;154(1):117-21. J Chromatogr. 1978. PMID: 670364 No abstract available.
• [Increased excretion of indolemelanogens in malignant melanoma without liver metastasis].

  Schwartze G, Haneke E. Schwartze G, et al. Dermatol Monatsschr. 1969;155(2):99-102. Dermatol Monatsschr. 1969. PMID: 5386292 German. No abstract available.
• Markers of melanogenesis in malignant melanoma.

  Matous B, Bubnova E, Budesinska A, Kostirova M. Matous B, et al. Sb Lek. 1994;95(4):333-38. Sb Lek. 1994. PMID: 8867704 Review.
• Role of the clinical laboratory in the diagnosis and management of malignant melanoma.

  Scott RE, Wilson DM. Scott RE, et al. Mayo Clin Proc. 1989 Jul;64(7):837-45. doi: 10.1016/s0025-6196(12)61757-1. Mayo Clin Proc. 1989. PMID: 2671522 Review.